Advanced Biomedical Technologies, Inc.
ABMTOTCHealthcare● Active
$0.00
+$0.00(+0.00%)
Market Cap$50000
P/E Ratio—
52W High$0.0005
52W Low$0.0001
Advanced Biomedical Technologies, Inc. (ABMT) Earnings: Dates, EPS & Revenue History
Quarterly EPS vs. estimates, revenue surprises, next earnings date, and analyst consensus.
ABMT · earnings · updated Jun 9, 2026
Latest Earnings
Q3 FY2021Report Date: Jul 31, 2021EPS Actual
-$0.00
Revenue
$0.00B
Fiscal Period
Q3 FY2021
FY ends December
Report Date
Jul 31, 2021
After Market Close
ABMT reports quarterly as a OTC-listed Medical - Devices company. Fiscal year ends in December. Data: FMP · Updated hourly.
Next Earnings Date
Days Away
84
days
Expected Date
Sep 1, 2026
Fiscal Period
Q3 FY2026
Release Time
◌ Time TBD (Unconfirmed)EPS Est.
$1.00
Rev. $1.80B
Days Away84
Expected DateSep 1, 2026
Fiscal PeriodQ3 FY2026
Release TimeTime TBD (Unconfirmed)
EPS Est.$1.00
Rev. Est.$1.80B
EPS & Revenue vs. Estimates
Actual (Beat)
Actual (Miss)
Estimated
Earnings History
| Period | Report Date | EPS Est. | EPS Actual | EPS Surpr. | Revenue | Rev. Est. | Rev. Surpr. |
|---|---|---|---|---|---|---|---|
| — Q3 FY2021 | Jul 31, 2021 | — | -$0.00 | — | $0.00B | — | — |
| — Q2 FY2021 | Jun 21, 2021 | — | -$0.00 | — | $0.00B | — | — |
| — Q1 FY2021 | Mar 22, 2021 | — | -$0.00 | — | $0.00B | — | — |
| — Q1 FY2021 | Jan 29, 2021 | — | -$0.00 | — | $0.00B | — | — |
| — Q3 FY2020 | Sep 21, 2020 | — | -$0.00 | — | $0.00B | — | — |
| — Q2 FY2020 | Jun 22, 2020 | — | -$0.00 | — | $-0.00B | — | — |
| — Q1 FY2020 | Mar 20, 2020 | — | -$0.00 | — | $0.00B | — | — |
| — Q4 FY2019 | Oct 31, 2019 | — | -$0.00 | — | $0.00B | — | — |
Q3 FY2021
Jul 31, 2021
EPS Actual
-$0.00
EPS Est.
—
EPS Surpr.
—
Revenue
$0.00B
Q2 FY2021
Jun 21, 2021
EPS Actual
-$0.00
EPS Est.
—
EPS Surpr.
—
Revenue
$0.00B
Q1 FY2021
Mar 22, 2021
EPS Actual
-$0.00
EPS Est.
—
EPS Surpr.
—
Revenue
$0.00B
Q1 FY2021
Jan 29, 2021
EPS Actual
-$0.00
EPS Est.
—
EPS Surpr.
—
Revenue
$0.00B
Q3 FY2020
Sep 21, 2020
EPS Actual
-$0.00
EPS Est.
—
EPS Surpr.
—
Revenue
$0.00B
Q2 FY2020
Jun 22, 2020
EPS Actual
-$0.00
EPS Est.
—
EPS Surpr.
—
Revenue
$-0.00B
Q1 FY2020
Mar 20, 2020
EPS Actual
-$0.00
EPS Est.
—
EPS Surpr.
—
Revenue
$0.00B
Q4 FY2019
Oct 31, 2019
EPS Actual
-$0.00
EPS Est.
—
EPS Surpr.
—
Revenue
$0.00B
Analyst Estimates
Limited analyst coverage (fewer than 3 analysts). Estimates may not reflect market consensus.
EPS Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q4 FY2024 | $1.54 | $1.54 | $1.54 | 1 |
| Q3 FY2024 | $1.34 | $1.34 | $1.34 | 1 |
| Q2 FY2024 | $1.58 | $1.58 | $1.58 | 1 |
| Q1 FY2024 | $2.09 | $2.09 | $2.09 | 1 |
| Q4 FY2023 | $1.39 | $1.39 | $1.39 | 1 |
| Q3 FY2023 | $1.19 | $1.19 | $1.19 | 1 |
Revenue Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q4 FY2024 | $-0.0B | $-0.0B | $-0.0B | 0 |
| Q3 FY2024 | $-0.0B | $-0.0B | $-0.0B | 0 |
| Q2 FY2024 | $-0.0B | $-0.0B | $-0.0B | 0 |
| Q1 FY2024 | $-0.0B | $-0.0B | $-0.0B | 0 |
| Q4 FY2023 | $-0.0B | $-0.0B | $-0.0B | 0 |
| Q3 FY2023 | $-0.0B | $-0.0B | $-0.0B | 0 |
Earnings Price Reaction
Closing price one trading day before vs. one trading day after each earnings release.
| Period | Report Date | EPS Beat/Miss | Price Before | Price After | 1D Reaction |
|---|---|---|---|---|---|
| — Q3 FY2021 | Jul 31, 2021 | — | $0.08 | $0.08 | +0.00% |
| — Q2 FY2021 | Jun 21, 2021 | — | $0.07 | $0.07 | +0.00% |
| — Q1 FY2021 | Mar 22, 2021 | — | $0.17 | $0.17 | +0.00% |
| — Q1 FY2021 | Jan 29, 2021 | — | $0.17 | $0.17 | +0.00% |
| — Q3 FY2020 | Sep 21, 2020 | — | $0.22 | $0.22 | +0.00% |
| — Q2 FY2020 | Jun 22, 2020 | — | $0.27 | $0.27 | +0.00% |
| — Q1 FY2020 | Mar 20, 2020 | — | $0.18 | $0.18 | +0.00% |
| — Q4 FY2019 | Oct 31, 2019 | — | $0.06 | $0.06 | +0.00% |
Q3 FY2021+0.00%
Report Date
Jul 31, 2021
EPS Beat/Miss
—
Price Before
$0.08
Price After
$0.08
Q2 FY2021+0.00%
Report Date
Jun 21, 2021
EPS Beat/Miss
—
Price Before
$0.07
Price After
$0.07
Q1 FY2021+0.00%
Report Date
Mar 22, 2021
EPS Beat/Miss
—
Price Before
$0.17
Price After
$0.17
Q1 FY2021+0.00%
Report Date
Jan 29, 2021
EPS Beat/Miss
—
Price Before
$0.17
Price After
$0.17
Q3 FY2020+0.00%
Report Date
Sep 21, 2020
EPS Beat/Miss
—
Price Before
$0.22
Price After
$0.22
Q2 FY2020+0.00%
Report Date
Jun 22, 2020
EPS Beat/Miss
—
Price Before
$0.27
Price After
$0.27
Q1 FY2020+0.00%
Report Date
Mar 20, 2020
EPS Beat/Miss
—
Price Before
$0.18
Price After
$0.18
Q4 FY2019+0.00%
Report Date
Oct 31, 2019
EPS Beat/Miss
—
Price Before
$0.06
Price After
$0.06
Beat Rate0 / 8 quarters
Largest Move+0.00% (Q3 FY2021)
Data: FMP /historical-price-eod/full · field: close
About Earnings & Data Methodology
Data source: Financial Modeling Prep (FMP) | Updated: Hourly | Surprise%: (Actual − Estimate) / |Estimate| × 100 | Fiscal year: ABMT ends December
Advanced Biomedical Technologies, Inc. (ABMT) most recently reported earnings on July 31, 2021 for Q3 FY2021, posting EPS of $-0.00 (in line with the analyst consensus of —). The next ABMT earnings date is expected around September 1, 2026.
Each quarter, investors track ABMT earnings for signals on forward guidance and business momentum. For longer-term revenue trends, see the Revenue tab. ABMT revenue tab →
Earnings Glossary
EPS (Earnings Per Share)
Net income ÷ diluted shares outstanding. The primary metric analysts use to gauge quarterly profitability.
Earnings Surprise %
(Actual − Estimate) / |Estimate| × 100. Positive = Beat. Negative = Miss.
Beat / Miss / In-Line
Beat = Actual ≥ Estimate. Miss = Actual < Estimate. In-Line = within ±1%.
BMO / AMC
Before Market Open / After Market Close. Two windows when companies typically release results.
Fiscal Quarter
ABMT's fiscal year ends in December. Fiscal quarters may not align with calendar quarters.
Analyst Consensus
Average EPS/Revenue forecast across all covering analysts. More analysts = more reliable estimate.
Figures tie to FMP earnings calendar, estimates, and SEC 10-Q/10-K filings where noted.
Frequently asked questions
ABMT earnings · 4 questionsAdvanced Biomedical Technologies, Inc.'s next earnings report is expected around September 1, 2026. ABMT typically reports quarterly — approximately every three months. The exact date is confirmed by the company 2–4 weeks before the release. Time is currently TBD; ABMT historically reports after market close (AMC).
ABMT earnings datewhen is ABMT earningsABMT next earnings datewhen does ABMT report earningsABMT earnings calendar
▸ Source: FMP · Advanced Biomedical Technologies, Inc. SEC filings · US GAAP · Advanced Biomedical Technologies, Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 9, 2026